Camp4 Therapeutics (CAMP) Profit After Tax (2023 - 2026)

Camp4 Therapeutics has reported Profit After Tax for 4 years, with the latest figure at -$18.3 million in Q1 2026.

• Quarterly Profit After Tax changed N/A year-over-year to -$18.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$86.3 million (down 119.32% YoY) and the FY2025 annual result came in at -$80.4 million, down 55.25% from the prior year.
• Profit After Tax climbed to -$18.3 million in Q1 2026 per CAMP's latest filing, from -$40.3 million in the prior quarter.
• Over five years, Profit After Tax peaked at -$11.7 million in Q3 2023 and troughed at -$40.3 million in Q4 2025.
• A 4-year average of -$16.3 million and a median of -$13.1 million in 2023 frame the typical range for Profit After Tax.
• The widest YoY moves for Profit After Tax: up 0.12% in 2025, down 203.37% in 2025.
• Over 4 years, Profit After Tax stood at -$13.0 million in 2023, then slipped by 2.22% to -$13.3 million in 2024, then tumbled by 203.37% to -$40.3 million in 2025, then jumped by 54.57% to -$18.3 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered -$18.3 million, -$40.3 million, and -$15.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.